CClinicalTrials.gg
Enrolling by invitationNCT04651673Updated Aug 11, 2025

Prescribed Knee Brace Treatments for Osteoarthritis of the Knee (Knee OA)

An observational study in Knee Osteoarthritis, sponsored by Össur Iceland ehf. Enrolling by invitation at 1 site in Sweden. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2025-08-11.

Sponsored by Össur Iceland ehf · Observational

Study type
Observational
Model
Other
Time perspective
Other
Enrollment
1,500
Ages
18 Years to 100 Years
Sex
All
01

Study summary

The study is a non-controlled retro- and prospective multi center patient registry study.

Subjects will be given a study ID number assigned at first brace fitting after consenting to partake. Participants will be asked to fill in a questionnaire either in electronic or paper version at first fitting. Additional follow up questionnaires will be implemented at 4 weeks, 6 months and 1 year post initial brace fitting. After that period patients will be contacted every year, until brace termination/ knee surgery or death.

Read the detailed description

This is a noninterventional registry study pertaining to knee OA braces. There are no comparative devices or treatments. Subjects are expected to follow the recommendations of the brace subscriber and other health care professionals at any time independent of their continuation within the registry.

Subjects will be enrolled at the clinic where their brace was prescribed or at the site where the brace was fitted.

There is no formal end date for this data registry. A revisit to this protocol may be motivated after 5 years, to assess if longer follow up is required.

For individual participants follow up will continue with annual questionnaires as long as the brace is in use. The questionnaires will be administered either through mail with a paper version, or through a link to an electronical version (ePRO). There is also a possibility of administrating the questionnaires as a phone guided interview, if that is a mean that serves the patient or clinics better. The planned follow-ups are at 4 weeks, 6 months, 1 year from brace prescription and then annually as long as participants are disposed as "ongoing" in the registry.

The questionnaires contains question about pain, function, medication, general brace use and quality of life question.

02

Conditions studied

  • Knee Osteoarthritis

Keywords

  • knee brace
  • conservative treatment
03

In context

Osteoarthritis, Knee

3,302 studies on the registry are indexed under Osteoarthritis, Knee; 608 are open to participants now.

This study's planned enrollment of 1,500 is above the median of 100 across 472 observational studies indexed under Osteoarthritis, Knee.

Browse Osteoarthritis, Knee studies →

Lead sponsor

Össur Iceland ehf is the lead sponsor of 23 studies on the registry; 4 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 7 (70%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Subjects are patients that have been prescribed knee braces for treatment of knee OA. The brace prescription is independent of the registry, i.e. no one is prescribed a brace because of the registry or for the purpose of this data collection per se

Inclusion criteria

  • Patients that are prescribed knee brace for symptomatic treatment of knee OA from partaking clinics
  • Older than 18 years

Exclusion criteria

Exclusion Criteria:

  • Younger than 18 years
  • Not willing or able to sign informed consent, or not cognitive impairments preventing understanding of the questionnaires.
05

Study design

Observational model
Other
Time perspective
Other
Enrollment
1,500 participants (estimated)
Target follow-up
5 Years
Patient registry
Yes

Interventions

  • OtherThis is a non interventional registry

    All patients, at listed investigational sites, that get prescription for a knee orthosis indicated for Knee OA symptomatic treatment, get an invite to partake in the evaluation registry.

06

What researchers measure

Primary outcomes

  1. Proportion of patients that are using the braces

    brace usage, days per week

    Time frame: 6 months follow up

  2. Change in Pain status compared to baseline

    Knee injury and Osteoarthritis Outcome Score (KOOS)-12

    Time frame: 6 months follow up

  3. Change in Mobility compared to baseline

    KOOS-12

    Time frame: 6 months follow up

  4. Proportion of patients that are still using the braces

    brace usage, days per week

    Time frame: 1 year follow up

  5. Change in Pain status compared to baseline

    KOOS-12

    Time frame: 1 year follow up

  6. Change in Mobility compared to baseline

    KOOS-12

    Time frame: 1 year follow up

  7. Sick leave after receiving the braces

    Proportion of sick leave

    Time frame: 6 months follow up

  8. Sick leave after receiving the braces

    Proportion of sick leave

    Time frame: 1 year follow up

  9. Changes in reported quality of life

    KOOS-12

    Time frame: 6 months follow up

  10. Changes in reported quality of life

    KOOS-12

    Time frame: 1 year follow up

  11. Changes in QALY's

    EQ-5D-5L

    Time frame: 6 months follow up

  12. Changes in QALY's

    EQ-5D-5L

    Time frame: 1 year follow up

Other outcomes

  1. The patients' satisfaction of the value/effectiveness of the brace

    Numeric Rating Scale (NRS) for satisfaction (0-10)

    Time frame: 6 months follow up

  2. The patients' satisfaction of the value/effectiveness of the brace

    NRS for satisfaction (0-10)

    Time frame: 1 year follow up

07

Study locations

1 site
  • Skånevård Nordost Region Skåne - Verksamhets område ortopedi, Kristianstad /Hässleholm
    Hässleholm, Skåne County, Sweden
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04651673
Lead sponsor
Össur Iceland ehf
Collaborators
Region Skane
Responsible party
Sponsor
First posted
Dec 3, 2020
Start date
Sep 9, 2020
Primary completion
Dec 31, 2030 (estimated)
Completion
Dec 31, 2030 (estimated)
Last update
Aug 11, 2025

Study contacts

Samuel Dencker, Dr
principal investigator · Region Skane

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion